Lifespan — Why We Age—and Why We Don't Have To

Aging as a Curable Condition

David Sinclair is a professor of genetics at Harvard Medical School whose research on sirtuins, NAD+, and the epigenome has placed him at the forefront of longevity science. His central thesis in Lifespan is both scientifically substantial and culturally provocative: aging is a disease — specifically, a loss of epigenetic information — and it is therefore potentially treatable.

This reframing matters. If aging is an inevitable process, the appropriate medical response is palliative: manage its symptoms as best we can. If aging is a disease with identifiable molecular mechanisms, the appropriate response is therapeutic: understand and interrupt those mechanisms. Sinclair argues vigorously for the second position.

The Information Theory of Aging

Sinclair’s theoretical contribution is the information theory of aging: the proposition that aging is fundamentally a loss of the epigenetic information that tells each cell which genes to express and which to silence. The genome (the DNA sequence) is like the physical disc; the epigenome (the patterns of gene expression) is like the data written on it. Aging is the corruption of that data — and just as corrupted digital data can sometimes be recovered from backup copies, the epigenome might be restorable.

This framework unifies several disparate observations about aging and suggests specific therapeutic targets.

Sirtuins and the Survival Circuit

Sinclair’s research on sirtuins — a class of proteins that respond to cellular stress by activating repair mechanisms — forms the experimental backbone of the book. Sirtuins are activated by caloric restriction, intermittent fasting, and exercise; they are inhibited by excess calories and sedentary behaviour. His research suggests that the modern lifestyle’s abundance and ease has chronically underactivated these longevity pathways.

NMN, Resveratrol, and the Longevity Supplement Stack

Sinclair is unusually candid about the supplements he personally takes, including NMN (a NAD+ precursor), resveratrol, and metformin. He is careful to distinguish between what the research supports and what he personally concludes — acknowledging that the gap between mouse results and human outcomes is real and significant. Readers should apply appropriate caution to the supplementation claims.

Aging as a Disease

The book’s most provocative move is rhetorical as much as scientific: Sinclair’s insistence that aging should be classified as a disease rather than an inevitable natural process. This reframing has real consequences, because it changes the appropriate medical response from palliation — managing the symptoms of decline — to treatment aimed at the underlying mechanism. If aging is simply the way of all flesh, then heart disease, cancer, and dementia are separate problems to be fought individually; if aging is itself a treatable condition that drives all of them, then targeting the aging process could address many diseases at once. Sinclair argues forcefully for the second view, and the argument is genuinely influential within the field even as it remains contested. Critics caution that reclassifying aging risks overpromising and could distort research priorities, but the provocation has succeeded in pushing longevity from the fringe toward the mainstream of biomedical ambition.

The Lifestyle Levers

Beyond the molecular theory, Lifespan offers concrete behavioral advice grounded in Sinclair’s account of the longevity pathways, and this is the material most readers can act on today. Because sirtuins and related repair mechanisms are activated by mild biological stress, Sinclair recommends practices that impose it: eating less and less often (caloric restriction and intermittent fasting), reducing protein and meat, exercising to the point of breathlessness, and exposing the body to hot and cold. The underlying logic is “hormesis” — the principle that small doses of stress trigger protective responses that leave the organism more resilient. Whatever one makes of the supplement claims, these lifestyle recommendations align broadly with the wider scientific consensus on healthy aging, and they give the book practical traction. Sinclair presents them not as guarantees but as the best current bets, and they are the parts of his program with the firmest evidentiary footing.

Optimism and Its Skeptics

The central tension of Lifespan is the gap between Sinclair’s enthusiasm and the maturity of the evidence, and the book is at its best when it acknowledges this and at its weakest when it does not. Much of the most striking research — the sirtuin activation, the epigenetic reprogramming that has rejuvenated cells and tissues in the laboratory — has been demonstrated in yeast, worms, and mice, and the leap to durable human benefit remains large and unproven. Sinclair is admirably candid about taking certain supplements himself while noting the human data is incomplete, but his framing throughout is that of an advocate convinced of a coming revolution, and his optimism sometimes outruns what the studies can support. Readers should weigh the book accordingly: the underlying science is real and important, the theoretical framework is genuinely illuminating, but the specific predictions and supplement recommendations call for the skepticism that any frontier field demands.

A Field in Motion

It is worth situating Lifespan within the rapidly evolving science of aging, a field that has moved from the scientific fringe to a major frontier of biomedical research in part because of advocates like Sinclair. The book functions as both a popularization of that research and a manifesto for accelerating it, and its publication helped bring longevity science to a mass audience and a wave of investment and attention. Sinclair writes with the conviction of a researcher who believes a revolution is imminent — that the first person to live well past a hundred and twenty may already be alive — and that conviction is contagious, even when it outruns the available data. Read critically, the book is an invaluable, accessible map of where the science stands and where its leading optimists believe it is heading, provided the reader keeps the distinction between established finding and hopeful extrapolation firmly in mind throughout.

Final Verdict

Lifespan is the most scientifically substantive longevity book for general readers. Its optimism may outpace its evidence, but the underlying science is genuine and the theoretical framework is important.

Our rating: 4.4/5 — Essential reading for anyone interested in the biology of aging. Apply the optimism with caution; the science is worth taking seriously.